Stock HRGN HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Harvard Apparatus Regenerative Technology Inc.

Equities

HRGN

US09074M2026

Advanced Medical Equipment & Technology

Market Closed - OTC Markets
Other stock markets
 01:39:40 2024-04-25 pm EDT 		5-day change 1st Jan Change
2.39 USD +3.02% Intraday chart for Harvard Apparatus Regenerative Technology Inc. +3.02% -52.10%
Apr. 15 Harvard Apparatus Regenerative Technology Inc. announced that it expects to receive $1.482101 million in funding CI
Mar. 28 Harvard Apparatus Regenerative Technology Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 11.68 15.77 11.74 24.75 66.96 69.6
Enterprise Value (EV) 1 10.37 15.04 11.3 23.45 65.85 69.21
P/E ratio -1.22 x -1.66 x -2.26 x -2.9 x -9.98 x -7.44 x
Yield - - - - - -
Capitalization / Revenue - - - - - 675,700,447 x
EV / Revenue - - - - - 671,972,291 x
EV / EBITDA -1.41 x -1.74 x -2.2 x -2.75 x -10.9 x -7.73 x
EV / FCF -2.06 x -4.55 x -4.5 x 40.3 x -10.3 x -28.8 x
FCF Yield -48.4% -22% -22.2% 2.48% -9.7% -3.48%
Price to Book 5.93 x 15.1 x 10.4 x -8.17 x -21 x 42.3 x
Nbr of stocks (in thousands) 5,670 7,843 9,388 10,761 12,174 13,947
Reference price 2 2.060 2.010 1.250 2.300 5.500 4.990
Announcement Date 3/29/19 3/27/20 4/13/21 3/31/22 3/30/23 3/28/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales - - - - - 0.103
EBITDA 1 -7.38 -8.656 -5.141 -8.529 -6.014 -8.955
EBIT 1 -7.641 -8.87 -5.325 -8.636 -6.066 -8.99
Operating Margin - - - - - -8,728.16%
Earnings before Tax (EBT) 1 -7.529 -8.332 -4.865 -7.978 -6.073 -8.945
Net income 1 -7.529 -8.332 -4.865 -7.978 -6.073 -8.945
Net margin - - - - - -8,684.47%
EPS 2 -1.687 -1.208 -0.5532 -0.7928 -0.5509 -0.6705
Free Cash Flow 1 -5.025 -3.303 -2.511 0.5815 -6.388 -2.406
FCF margin - - - - - -2,335.44%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 3/29/19 3/27/20 4/13/21 3/31/22 3/30/23 3/28/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 1.31 0.72 0.44 1.3 1.11 0.38
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -5.02 -3.3 -2.51 0.58 -6.39 -2.41
ROE (net income / shareholders' equity) -279% -545% -439% 838% 595% -679%
ROA (Net income/ Total Assets) -124% -240% -164% -274% -178% -224%
Assets 1 6.052 3.476 2.973 2.913 3.417 3.991
Book Value Per Share 2 0.3500 0.1300 0.1200 -0.2800 -0.2600 0.1200
Cash Flow per Share 2 0.2300 0.1100 0.1100 0.1200 0.1000 0.0300
Capex 1 0.13 0.13 0.01 - 0.01 0.01
Capex / Sales - - - - - 10.68%
Announcement Date 3/29/19 3/27/20 4/13/21 3/31/22 3/30/23 3/28/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC. Stock Harvard Apparatus Regenerative Technology Inc.
-52.10% 34.21M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+8.07% 219B
DANAHER CORPORATION Stock Danaher Corporation
+6.59% 183B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+11.26% 133B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+26.57% 108B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+0.65% 63.06B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+13.35% 52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-0.62% 48.2B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-0.93% 40.37B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+11.54% 39.35B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. HRGN Stock
  4. Financials Harvard Apparatus Regenerative Technology Inc.